Search Results for keywords:"Scientific Review Officer"

The National Institute of Neurological Disorders and Stroke announced a closed meeting to review grant applications related to analgesic discovery as part of the HEAL Initiative. The meeting, scheduled for April 7, 2025, will occur virtually and is not open to the public due to the potential discussion of confidential information. Details about the meeting and contact information for the Scientific Review Officer, Dr. Abhignya Subedi, are provided. This notice highlights the importance of protecting sensitive personal and commercial information during the evaluation process.

The Centers for Disease Control and Prevention (CDC) announced a closed meeting for the Disease, Disability, and Injury Prevention and Control Special Emphasis Panel. The meeting, which will be held on June 10, 2021, via web conference, is closed to the public due to the possibility of revealing confidential information and personal privacy concerns. The agenda for this meeting includes reviewing and evaluating grant applications related to potential risk factors for Amyotrophic Lateral Sclerosis (ALS). For more information, interested parties can contact Mikel Walters, Ph.D., the Scientific Review Officer.

The National Center for Advancing Translational Sciences is holding a closed meeting to review grant applications on February 12, 2021. The meeting is closed to the public due to potential disclosure of confidential information and personal privacy concerns. It will take place virtually through the National Institutes of Health. Dr. Carol Lambert will serve as the Scientific Review Officer for this event.

The Center for Scientific Review at the National Institutes of Health is holding a series of closed virtual meetings throughout April and May 2025. These meetings are organized to review and evaluate various grant applications. The discussions will be confidential to protect sensitive information, including trade secrets and personal data. For further details about the meetings, contact information for each meeting's Scientific Review Officer is provided in the document.

The National Institutes of Health (NIH) announced a closed meeting of the NHLBI Mentored Clinical and Basic Science Study Section. The meeting will take place virtually on February 27-28, 2025, from 10:00 a.m. to 6:00 p.m. The meeting will be closed to protect confidential information related to grant applications, including trade secrets and personal information. Dr. Manoj Kumar Valiyaveettil can be contacted for further details regarding this meeting.

The National Heart, Lung, and Blood Institute, part of the National Institutes of Health, has announced a closed meeting for the Heart, Lung, and Blood Initial Review Group to discuss grant applications. This virtual meeting, scheduled for February 20-21, 2025, from 9:00 a.m. to 12:00 p.m., will review applications that may involve confidential information, including trade secrets or personal data. Because of this sensitive content, the meeting will not be open to the public. For more information, Fungai Chanetsa, the Scientific Review Officer, can be contacted at the provided details.

The National Institute on Drug Abuse is holding a closed meeting to review grant applications as part of the NIDA Centers Grant Program. This meeting will take place virtually on May 2, 2025, from 10:30 a.m. to 4 p.m. The purpose of the meeting is to discuss confidential information, including trade secrets and personal details, which is why it will not be open to the public. Interested parties can contact Marisa Srivareerat, Ph.D., the Scientific Review Officer, for more information.

The National Institute of General Medical Sciences announced a closed meeting on March 19, 2021, for the review of grant applications related to the Institutional Development Award Program Infrastructure for Clinical and Translational Research. The meeting will be held as a video conference and is closed to the public to protect confidential information such as trade secrets and personal details of individuals involved. The contact for this meeting is Dr. Saraswathy Seetharam, the Scientific Review Officer.

The National Institutes of Health announced a closed meeting for the National Institute on Drug Abuse Special Emphasis Panel. This meeting, scheduled for May 2, 2025, will be conducted virtually and will review grant applications related to drug use health consequences. The meeting is closed to protect personal privacy and confidential information. Sudhirkumar U. Yanpallewar, a Scientific Review Officer, can be contacted for further information.

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) announced a closed meeting scheduled for February 17-18, 2021. The meeting is organized to review and evaluate grant applications and will be held via video at the National Institutes of Health in Bethesda, MD. The grant discussions will remain private to protect confidential information and personal privacy. For further information, individuals may contact Lan Tian, Ph.D., the Scientific Review Officer at NIDDK.